Skip to content

13F-HR filed by AIGH Capital Management LLC

AIGH Capital Management LLC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 54 holding rows worth $321,764,000.

Accession
0001214659-22-013522
Filed
2022-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 98 entries on the cover page, a total value of $321,764,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $321,764,000 with VALUE read as thousands by filing date, 13F file number 028-20823. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
iShares Russell 2000 ETF464287655SHS410,000$67,617,000thousands by filing dateput
ADTRAN HOLDINGS INC00486H105COM1,161,019$22,733,000thousands by filing date
AVEO PHARMACEUTICALS INC053588307COM2,739,255$22,544,000thousands by filing date
MATERION CORP576690101COM241,189$19,295,000thousands by filing date
TRANSPHORM INC89386L100COM3,772,875$18,978,000thousands by filing date
DZS INC268211109COMMON STOCK1,677,879$18,960,000thousands by filing date
AVIAT NETWORKS INC05366Y201COMMON STOCK535,918$14,674,000thousands by filing date
TELA BIO INC872381108COM1,529,669$13,033,000thousands by filing date
INDIE SEMICONDUCTOR INC45569U101CLASS A COM1,452,766$10,634,000thousands by filing date
ANI PHARMACEUTICALS INC00182C103COM314,406$10,105,000thousands by filing date
PARATEK PHARMACEUTICALS INC699374302Equity3,887,172$9,990,000thousands by filing date
CALAMP CORP128126109COMMON STOCK2,336,942$8,974,000thousands by filing date
SONO GROUP N VN81409109COM3,516,129$8,931,000thousands by filing date
SILICON MOTION TECHNOLOGY CORP SPONSORED ADR82706C108ADR114,400$7,458,000thousands by filing date
THERATECHNOLOGIES INC COM88338H100COM2,913,067$6,909,000thousands by filing date
AIRGAIN INC00938A104COM727,484$5,245,000thousands by filing date
EVERSPIN TECHNOLOGIES INC30041T104COMMON STOCK854,430$4,947,000thousands by filing date
SCPHARMACEUTICALS INC810648105COM757,063$4,936,000thousands by filing date
SCYNEXIS INC811292200COM NEW1,957,054$4,696,000thousands by filing date
ICAD INC44934S206COM NEW1,755,634$3,686,000thousands by filing date
BK Technologies Corp.05587G104COM1,373,750$3,310,000thousands by filing date
MEDICENNA THERAPEUTICS F58490H107FOREIGN CANADIAN3,850,154$3,193,000thousands by filing date
RF INDUSTRIES LTD749552105COMMON STOCK512,037$2,944,000thousands by filing date
APOLLO ENDOSURGERY INC03767D108COM508,536$2,802,000thousands by filing date
IDEAL PWR INC451622203COM NEW213,368$2,208,000thousands by filing date
LIGHTPATH TECHNOLOGIES INC532257805COM CL A2,039,832$2,183,000thousands by filing date
ARDELYX INC039697107COM1,487,476$1,770,000thousands by filing date
X4 Pharmaceuticals, Inc.98420X103COM997,719$1,706,000thousands by filing date
EVOLUS INC30052C107COM200,000$1,610,000thousands by filing date
CAPSTONE GREEN ENERGY CORP.14067D508Common Stock900,000$1,593,000thousands by filing date
RVL PHARMACEUTICALS PLCG6S41R101COM739,531$1,553,000thousands by filing date
COGNITION THERAPEUTICS INC19243B102COM798,335$1,516,000thousands by filing date
CONTEXT THERAPEUTICS INC21077P108COM1,291,771$1,434,000thousands by filing date
TRANSCODE THERAPEUTICS INC89357L105CMN1,289,000$1,418,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock1,200,000$1,140,000thousands by filing date
FRANKLIN WIRELESS CORP355184102COM390,000$1,139,000thousands by filing date
VACCINEX INC918640103CMN2,081,801$1,030,000thousands by filing date
MYOMO INC62857J201COM NEW617,179$999,000thousands by filing date
SOLENO THERAPEUTICS INC834203309COM424,089$708,000thousands by filing date
PROCESSA PHARMACEUTICALS INC COM NEW74275C205Stock303,703$686,000thousands by filing date
CELLECTAR BIOSCIENCES INC15117F807COM174,422$586,000thousands by filing date
ABEONA THERAPEUTICS INC00289Y206COM NEW140,644$428,000thousands by filing date
Ohr Pharmaceutical Inc64132K102COM872,023$345,000thousands by filing date
CAMBIUM NETWORKS CORPORATIONG17766109COMMON STOCK-FO19,182$325,000thousands by filing date
ATHENEX INC04685N103COM1,000,134$269,000thousands by filing date
NLS PHARMACEUTICS LTDH57830111*W EXP 02/02/202633,361$158,000thousands by filing date
SAVERONE 2014 LTD80516T113*W EXP 06/02/202428,330$128,000thousands by filing date
CYCLO THERAPEUTICS INC23254X110*W EXP 12/11/202219,795$77,000thousands by filing date
NLS PHARMACEUTICS LTDH57830111*W EXP 02/02/202194,060$49,000thousands by filing datecall
SAVERONE 2014 LTD80516T113*W EXP 06/02/202141,364$42,000thousands by filing datecall
REZOLUTE INC76200L309COMMON STOCK11,866$33,000thousands by filing date
CYCLO THERAPEUTICS INC23254X110*W EXP 12/11/20273,736$26,000thousands by filing datecall
PARABELLUM ACQUISITION CORP69901P117Common450,214$8,000thousands by filing date
PARABELLUM ACQUISITION CORP69901P117Common139,072$3,000thousands by filing datecall

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-22-013522this filing2022-11-14acceptance time not in the bulk data set